HIV Prevention Trials Network

Studies 

HPTN 059

Phase II Expanded Safety and Acceptability Study of the Vaginal Microbicide 1% Tenofovir Gel

 

Q & A Categories

  • Study Design

  • Eligibility Criteria

  • Administrative, Behavioral, and Regulatory Procedures

  • Clinical Procedures

  • Laboratory Procedures

  • Study Product Considerations

  • Data Collection and Management

  • Human Subjects Considerations

  • Study Monitoring Considerations

  • Other

 
Site Map | HPTN Disclaimer | Webmaster | ©2008 Family Health International